← Back to Clinical Trials
Recruiting NCT07500883

NCT07500883 Basic Body Awareness Therapy Added to Scoliosis-Specific Exercise in Adolescents With Scoliosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07500883
Status Recruiting
Phase
Sponsor Gözde Yagci (Gür)
Condition Adolescent Idiopathic Scoliosis (AIS)
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2025-11-12
Primary Completion 2026-04

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Scoliosis-specific exercisesAwareness therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2025-11-12 with a primary completion date of 2026-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this randomised clinical trial is to evaluate whether adding Basic Body Awareness Therapy (BBAT) to scoliosis-specific exercises can improve body awareness, quality of life and scoliosis-speficic outcomes in adolescents aged 10-17 years with adolescent idiopathic scoliosis (AIS). The main questions it aims to answer are: Does the addition of BBAT to scoliosis-specific exercises lead to greater improvements in body awareness compared to scoliosis-specific exercises alone? Does adding BBAT improve trunk proprioception, scoliosis-related parameters, and health-related quality of life in adolescents with AIS? H1: Adolescents with idiopathic scoliosis who receive Basic Body Awareness Therapy in addition to scoliosis-specific exercises will demonstrate greater improvements in body awareness compared to those receiving scoliosis-specific exercises alone. H2: Adolescents receiving Basic Body Awareness Therapy in addition to scoliosis-specific exercises will demonstrate greater improvements in scoliosis-related clinical parameters compared to those receiving scoliosis-specific exercises alone. H3: Adolescents receiving Basic Body Awareness Therapy in addition to scoliosis-specific exercises will demonstrate greater improvements in both general and scoliosis-specific quality of life compared to those receiving scoliosis-specific exercises alone.

Eligibility Criteria

Inclusion Criteria: * Diagnosed of adolescent idiopathic scoliosis * Age between 10 and 17 years * Cobb angle ≥15° * No previous or concurrent scoliosis treatment * Risser sign between 0 and 4 Exclusion Criteria: * Evidence of congenital scoliosis or other spinal deformities (e.g., hyperkyphosis, pectus deformities) * Diagnosis of neuromuscular, rheumatologic, neurological, cardiovascular, pulmonary disorders * Regular participation in sports * History of spinal orthosis use or scoliosis surgery.

Contact & Investigator

Central Contact

SENA NUR YAYLACI, MSc, PT

✉ senayaylaciii@gmail.com

📞 +905446515570

Principal Investigator

Gözde Yağcı, Prof. Dr.

STUDY DIRECTOR

Hacettepe University

Frequently Asked Questions

Who can join the NCT07500883 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 17 Years, studying Adolescent Idiopathic Scoliosis (AIS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07500883 currently recruiting?

Yes, NCT07500883 is actively recruiting participants. Contact the research team at senayaylaciii@gmail.com for enrollment information.

Where is the NCT07500883 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07500883 clinical trial?

NCT07500883 is sponsored by Gözde Yagci (Gür). The principal investigator is Gözde Yağcı, Prof. Dr. at Hacettepe University. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology